Most Active Stories
- In projects big and small, Watertown’s downtown reviving – but some say city government lacks vision
- Audio postcard: Sackets Harbor choral group rehearses
- Winter storm brings heavy snow to the region
- Closings and cancelations for Wednesday
- Oswego County nuclear plant shut down for the second time in less than a week
Competitor Permitted To Sell Lipitor Generic
STEVE INSKEEP, HOST:
NPR's business news starts with cheaper cholesterol drugs for many Americans.
(SOUNDBITE OF MUSIC)
INSKEEP: The drug maker Pfizer has lost the patent on its drug Lipitor. The patent expired in the United States yesterday. And on the same day, regulators granted an Indian company approval to sell a cheaper, generic version of the cholesterol drug in the U.S. market.
Pfizer has sold about $100 billion worth of Lipitor since 1997. Revenues are now expected to plummet. And more generic rivals are expected to hit the market soon, meaning consumers will be paying a fraction of the previous cost for that medication. Transcript provided by NPR, Copyright National Public Radio.